| USP订购编号 |
美国药典，USP分析标准品，英文名称，规格 |
CAS编号查询 |
UN编号对照 |
| USP-1362307 |
Levomenol (100 mg) |
23089-26-1 |
|
| 2906195000 |
|
|
|
| USP-1362359 |
Levomethorphan Solution (3 x 1.2 mL) (0.1 mg/mL 3-Methoxy-17-methylmorphinan in methanol) |
125-70-2 |
UN1230 |
| USP-1366567 |
Linalool (0.3 mL) |
78-70-6 |
|
| 2905220000 |
|
|
|
| USP-1366578 |
Linalyl Acetate (0.3 mL) |
115-95-7 |
|
| 2915399500 |
|
|
|
| USP-1367647 |
Linoleyl Alcohol (5 X 30 mg) |
506-43-4 |
|
| 2905299000 |
|
|
|
| USP-1367676 |
Conjugated Linoleic Acids – Free Fatty Acid (3 x 100 mg) |
N/A |
|
| 3823194000 |
|
|
|
| USP-1367699 |
Linolenyl Alcohol (5 x 30 mg) |
506-44-5 |
|
| 2905299000 |
|
|
|
| USP-1367708 |
Linoleoyl Polyoxylglycerides (150 mg) |
N/A |
|
| 3822190000 |
|
|
|
| USP-1370804 |
Lutein (3 X 50 mg) |
127-40-2 |
|
| 3203000000 |
|
|
|
| USP-1372424 |
Polyoxyl 4 Lauryl Ether (1 mL) |
5274-68-0 |
UN3082 |
| USP-1372504 |
Polyoxyl Oleate (500 mg) |
9004-96-0 |
|
| 3907990100 |
|
|
|
| USP-1374408 |
Malathion (500 mg) |
121-75-5 |
UN3018 |
| USP-1380513 |
Memantine Related Compound A (50 mg) (1,3-Dimethyladamantane) |
702-79-4 |
UN3295 |
| USP-1380535 |
Memantine Related Compound C (50 mg) (1-Chloro-3,5-dimethyladamantane) |
707-36-8 |
|
| 2903890002 |
|
|
|
| USP-1380546 |
Memantine Related Compound D (50 mg) (1-Bromo-3,5-dimethyladamantane) |
941-37-7 |
|
| 2903890002 |
|
|
|
| USP-1395204 |
Metacresol (1 mL) |
108-39-4 |
UN2076 |
| USP-1411016 |
Methimazole Related Compound A (3 x 50 mg) (2,2-Dimethoxy-N-methylethanamine) |
122-07-6 |
UN1989 |
| USP-1411038 |
Methimazole Related Compound C (3 x 50 mg) (1-Methyl-2-(methylthio)-1H-imidazole) |
14486-52-3 |
|
| 2933290000 |
|
|
|
| USP-1418004 |
Methoxyflurane (0.5 mL) |
76-38-0 |
UN1993 |
| USP-1424051 |
Methyl Acetate (1.2 mL/ampule; 3 ampules) |
79-20-9 |
UN1231 |
| USP-1424062 |
Methyl Acrylate, Methyl Methacrylate and Methacrylic Acid (7:3:1) Copolymer 280000 Dispersion (200 mg) |
26936-24-3 |
|
| 3906906000 |
|
|
|
| USP-1424109 |
Methyl Alcohol (3 x 1.5 mL) |
67-56-1 |
UN1230 |
| USP-1424153 |
3-Methyl-1-butanol (1.2 mL/ampule; 3 ampules) |
123-51-3 |
UN1105 |
| USP-1424233 |
Methyl Caprate (3 x 100 mg) |
110-42-9 |
|
| 2915900000 |
|
|
|
| USP-1424255 |
Methyl Caprylate (300 mg) |
111-11-5 |
|
| 2915900000 |
|
|
|
| USP-1430101 |
Methyl Ethyl Ketone (1.2 mL/ampule; 3 ampules) |
78-93-3 |
UN1193 |
| USP-1430305 |
Methyl Laurate (5 x 100 mg) |
111-82-0 |
|
| 2915900000 |
|
|
|
| USP-1430327 |
Methyl Linoleate (5 x 50 mg) |
112-63-0 |
|
| 2916151000 |
|
|
|
| USP-1431501 |
Methyl Myristate (3 x 100 mg) |
124-10-7 |
|
| 2915900000 |
|
|
|
| USP-1431556 |
Methyl Oleate (5 x 100 mg) |
112-62-9 |
|
| 2916155100 |
|
|
|
| USP-1431625 |
Methyl Palmitoleate (3 x 100 mg) |
1120-25-8 |
|
| 2916196000 |
|
|
|
| USP-1437053 |
2-Methyl-1-propanol (1.2 mL/ampule; 3 ampules) |
78-83-1 |
UN1212 |
| USP-1437202 |
Methylpyrrolidone (2 g) |
872-50-4 |
|
| 2933790002 |
|
|
|
| USP-1437392 |
Methyl Ricinoleate (100 mg) |
141-24-2 |
|
| 2918195000 |
|
|
|
| USP-1437450 |
Methyl Salicylate (2 mL) |
119-36-8 |
|
| 2918230000 |
|
|
|
| USP-1443952 |
Mineral Oil (1.5 mL) |
8042-47-5 |
|
| 2710194540 |
|
|
|
| USP-1445571 |
1-Mononitroglycerin (2 ampules x 1 mL) |
624-43-1 |
UN1648 |
| USP-1445584 |
2-Mononitroglycerin (2 ampules x 1 mL) |
620-12-2 |
UN1648 |
| USP-1445925 |
Monoethanolamine (1 mL) |
141-43-5 |
UN2491 |
| USP-1448854 |
Low Molecular Weight Heparin Molecular Weight Calibrant (10.6 mg) |
9041/8/1 |
|
| 3001900190 |
|
|
|
| USP-1457458 |
Narasin (125 mg) |
N/A |
UN2811 |
| USP-1463326 |
Nicotine Related Compound A (20 mg) (1,2,3,6-tetrahydro-2,3′-bipyridine) |
2743-90-0 |
|
| 2939800000 |
|
|
|
| USP-1463337 |
Nicotine Related Compound B (20 mg) (3-(1-methyl-1H-pyrrol-2-yl)pyridine) |
487-19-4 |
|
| 2939800000 |
|
|
|
| USP-1463371 |
Nicotine Related Compound F (20 mg) (3-(pyrrolidin-2-yl)pyridine) |
5746-86-1 |
|
| 2939790000 |
|
|
|
| USP-1463382 |
Nicotine Related Compound G (20 mg) ((S)-3-(piperidin-2-yl)pyridine) |
494-52-0 |
UN3140 |
| USP-1466506 |
Diluted Nitroglycerin (5 ampules, approx. 200 mg of a 0.974% solution in propylene glycol each) (需冷链运输) |
55-63-0 |
UN1204 |
| USP-1466607 |
N-Nitrosomethylphenylamine (NMPA) (1 mL (1 mg/mL)) (N-Methyl-N-nitrosophenylamine) |
614-00-6 |
UN1230 |
| USP-1466641 |
N-Nitrosodibutylamine (NDBA) (1 mL (1 mg/mL)) (N-Butyl-N-nitroso-1-butanamine) |
924-16-3 |
UN1230 |
| USP-1466652 |
N-Nitrosodiethylamine (NDEA) (1 mL (1 mg/mL)) (N-Ethyl-N-nitrosoethanamine) |
55-18-5 |
UN1230 |
| USP-1466663 |
N-Nitrosodiisopropylamine (NDIPA) (1 mL (1 mg/mL)) (N-Isopropyl-N-nitrosoisopropylamine) |
601-77-4 |
UN1230 |
| USP-1466674 |
N-Nitrosodimethylamine (NDMA) (1 mL (1 mg/mL)) (N-Methyl-N-nitrosomethanamine) |
62-75-9 |
UN1230 |
| USP-1466685 |
N-Nitrosoethylisopropylamine (NEIPA) (1 mL (1 mg/mL)) (N-Ethyl-N-nitroso-2-propanamine) |
16339-04-1 |
UN1230 |
| USP-1466696 |
N-Nitrosomethylaminobutyric Acid (NMBA) (1 mL (1 mg/mL)) (4-[Methyl(nitroso)amino]butanoic acid) |
61445-55-4 |
UN1648 |
| USP-1467837 |
PS NMR System Suitability (1 mg) |
N/A |
|
| 3913908000 |
|
|
|
| USP-1467950 |
Nonoxynol 9 (0.5 mL) |
68412-54-4 |
UN3082 |
| USP-1477411 |
Octocrylene (500 mg) |
6197-30-4 |
|
| 2926900005 |
|
|
|
| USP-1477502 |
Octoxynol 9 (200 mg) |
9002-93-1 |
UN3082 |
| USP-1477808 |
Octyldodecanol (3 x 100 mg) |
5333-42-6 |
|
| 2905199095 |
|
|
|
| USP-1477900 |
Octinoxate (500 mg) |
5466-77-3 |
|
| 2918992090 |
|
|
|
| USP-1477943 |
Octisalate (400 mg) (Octyl Salicylate) |
118-60-5 |
|
| 2918230000 |
|
|
|
| USP-1478130 |
Oleic Acid (1 g) |
112-80-1 |
|
| 2916151000 |
|
|
|
| USP-1478152 |
Oleoyl Polyoxylglycerides (100 mg) |
N/A |
|
| 3824994100 |
|
|
|
| USP-1478174 |
Oleyl Oleate 95 (125 mg) |
3687-45-4 |
|
| 2916155100 |
|
|
|
| USP-1478185 |
Oleyl Alcohol (5 x 50 mg) |
143-28-2 |
|
| 2905299000 |
|
|
|
| USP-1478200 |
Oleyl Oleate (0.5 mL) |
3687-45-4 |
|
| 2916151000 |
|
|
|
| USP-1478210 |
Oligosaccharide System Suitability Mixture A (20 ug) |
N/A |
|
| 3822190000 |
|
|
|
| USP-1478221 |
Oligosaccharide System Suitability Mixture B (20 ug) |
N/A |
|
| 3822190000 |
|
|
|
| USP-1478232 |
Oligosaccharide System Suitability Mixture C (20 ug) |
N/A |
|
| 3822190000 |
|
|
|
| USP-1478243 |
Oligosaccharide System Suitability Mixture D (20 ug) |
N/A |
|
| 3822190000 |
|
|
|
| USP-1478254 |
Olive Oil (5 x 200 mg) |
8001-25-0 |
|
| 1509902000 |
|
|
|
| USP-1478442 |
Omega-3 Free Fatty Acids (750 mg) |
N/A |
|
| 3824994100 |
|
|
|
| USP-1479053 |
Orphenadrine Related Compound E (50 mg) (N,N-Dimethyl-2-[phenyl(m-tolyl)methoxy]ethanamine) |
21945-86-8 |
|
| 2922199695 |
|
|
|
| USP-1491503 |
Padimate O (300 mg) |
21245-02-3 |
|
| 2922493800 |
|
|
|
| USP-1492040 |
Palm Oil (1 g) |
8002-75-3 |
|
| 1511900000 |
|
|
|
| USP-1500557 |
Peanut Oil (1 g) |
8002/3/7 |
|
| 1508900000 |
|
|
|
| USP-1504933 |
Pentane (1.2 mL/ampule; 3 ampules) |
109-66-0 |
UN1265 |
| USP-1504955 |
1-Pentanol (1.2 mL/ampule; 3 ampules) |
71-41-0 |
UN1105 |
| USP-1510801 |
Perflubron (0.5 mL) |
423-55-2 |
|
| USP-1724317 |
Zalcitabine Related Compound A (50 mg) (2′,3′-Didehydro-2′,3′-dideoxycytidine) |
7481-88-1 |
|
| 2934990005 |
|
|
|
| USP-1724361 |
Zaleplon Related Compound A (15 mg) ((E)-N-(3-[3-(dimethylamino)acryloyl]phenyl)-N-ethylacetamide) |
1227694-96-3 |
|
| 2924296000 |
|
|
|
| USP-1724372 |
Zaleplon Related Compound B (15 mg) (N-[3-(3-Cyanopyrazolo[1,5-alpha]pyrimidin-5-yl)phenyl]-N-ethylacetamide) |
478081-98-0 |
|
| 2933599550 |
|
|
|
| USP-1724383 |
Zaleplon Related Compound C (25 mg) (7-[3-(N-ethylacetamido)phenyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide) |
940951-54-2 |
|
| 2933599550 |
|
|
|
| USP-1724408 |
Ziprasidone Hydrochloride (200 mg) |
138982-67-9 |
|
| 2934200000 |
|
|
|
| USP-1724419 |
Ziprasidone Related Compound A (10 mg) (3-(Piperazin-1-yl)benzo[d]isothiazole monohydrochloride) |
87691-88-1 |
UN3077 |
| USP-1724441 |
Ziprasidone Related Compound C (10 mg) (5,5′-Bis(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6,6′-dichloro-3-hydroxy-3,3′-biindoline-2,2′-dione) |
N/A |
|
| 2934200000 |
|
|
|
| USP-1724452 |
Ziprasidone Related Compound D (10 mg) (3-(Benzo[d]isothiazol-3-yl)-5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one) |
N/A |
|
| 2934200000 |
|
|
|
| USP-1724474 |
Ziprasidone Related Compound F (15 mg) (Sodium 2-(2-amino-5-{2-[4-(benzo[d]isothiazol-3-yl)piperazin-1-yl]ethyl}-4-chlorophenyl)acetate monohydrate) |
N/A |
|
| 2934990005 |
|
|
|
| USP-1724500 |
Zidovudine (400 mg) |
30516-87-1 |
|
| 2934990005 |
|
|
|
| USP-1724521 |
Zidovudine Related Compound B (25 mg) (3′-chloro-3′-deoxythymidine) |
25526-94-7 |
|
| 2934990005 |
|
|
|
| USP-1724532 |
Zidovudine Related Compound C (100 mg) (thymine) |
65-71-4 |
|
| 2933599550 |
|
|
|
| USP-1724543 |
Zidovudine Related Compound D (50 mg) ([1-(2-Deoxy-beta-D-ribofuranosyl)]thymine) |
50-89-5 |
|
| 2934990005 |
|
|
|
| USP-1724656 |
Zileuton (150 mg) |
111406-87-2 |
|
| 2934990005 |
|
|
|
| USP-1724667 |
Zileuton Related Compound A (50 mg) (N-(1-Benzo[b]thien-2-ylethyl) urea) |
171370-49-3 |
|
| 2934990005 |
|
|
|
| USP-1724678 |
Zileuton Related Compound B (50 mg) (2-(Benzo[b]thien-2-oyl)benzo[b]thiophene) |
97978-07-9 |
|
| 2934990005 |
|
|
|
| USP-1724689 |
Zileuton Related Compound C (50 mg) (1-(Benzo[b]thiophen-2-yl)ethan-1-one) |
22720-75-8 |
|
| 2934990005 |
|
|
|
| USP-1724703 |
Zinc Acetate (50 mg) |
5970-45-6 |
UN3077 |
| USP-1724736 |
Zinc Chloride (100 mg) |
7646-85-7 |
UN2331 |
| USP-1724747 |
Zinc Oxide (200 mg) |
1314-13-2 |
UN3077 |
| USP-1724758 |
Zinc Stearate (200 mg) (Mixture of zinc stearate and zinc palmitate) |
N/A |
|
| 2915700100 |
|
|
|
| USP-1724769 |
Zinc Sulfate (1 g) |
7446-19-7 |
UN3077 |
| USP-1724772 |
Ziziphus Jujuba Spinosa Seed Dry Extract (750 mg) |
N/A |
|
| 1302190200 |
|
|
|
| USP-1724780 |
Zinc Undecylenate (200 mg) |
557-08-4 |
|
| 2916196000 |
|
|
|
| USP-1724827 |
Zoledronic Acid (150 mg) |
165800-06-6 (Monohydrate) |
UN3077 |
| USP-1724838 |
Zoledronic Acid Related Compound A (30 mg) (2-(1H-Imidazol-1-yl)acetic acid) |
22884-10-2 |
|
| 2933399095 |
|
|
|
| USP-1724918 |
Zolpidem Related Compound A (15 mg) (N,N-Dimethyl-2-[7-methyl-2-p-tolylimidazo[1,2-a]pyridin-3-yl]acetamide) |
1346600-85-8 |
|
| 2933997500 |
|
|
|
| USP-1725003 |
Zonisamide (200 mg) |
68291-97-4 |
|
| 2935904000 |
|
|
|
| USP-1725014 |
Zonisamide Related Compound A (20 mg) (1,2-benzisoxazole-3-methanesulfonic acid sodium salt) |
73101-64-1 |
|
| 2934990005 |
|
|
|
| USP-1725036 |
Zonisamide Related Compound C (20 mg) (N’-(benzisoxazol-3-ylmethylsulfonyl)-N,N-dimethylformimidamide) |
N/A |
|
| 2934990005 |
|
|
|
| USP-1727009 |
Zolmitriptan (200 mg) |
139264-17-8 |
|
| 2934990005 |
|
|
|
| USP-1727018 |
Zolmitriptan R-Isomer (20 mg) ((R)-4-({3-[2-(Dimethylamino)ethyl]indol-5-yl}methyl)oxazolidin-2-one) |
139264-24-7 |
|
| 2934990005 |
|
|
|
| USP-1727020 |
Zolmitriptan Related Compound A (20 mg) ((S)-4-({3-[2-(Methylamino)ethyl]-1H-indol-5-yl}methyl)oxazolidin-2-one) |
139264-35-0 |
|
| 2934990005 |
|
|
|
| USP-1727031 |
Zolmitriptan Related Compound B (20 mg) ((S)-2-Amino-3-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}propan-1-ol) |
139264-69-0 |
|
| 2934990005 |
|
|
|
| USP-1727064 |
Zolmitriptan Related Compound E (25 mg) ((S)-N,N-dimethyl-2-{5-[(2-oxooxazolidin-4-yl)methyl]-1H-indol-3-yl}ethanamine oxide) |
251451-30-6 |
|
| 2934990005 |
|
|
|
| USP-1727075 |
Zolmitriptan Related Compound F (25 mg) (2,2′-[4-(Dimethylamino)butane-1,1-diyl]bis{5-[(S)-(2-oxooxazolidin-4-yl)methyl]-3-(2-dimethylaminoethyl)indole}) |
1350928-05-0 |
|
| 2934990005 |
|
|
|
| USP-1727086 |
Zolmitriptan Related Compound G (25 mg) ((S)-4-(4-Aminobenzyl)oxazolidin-2-one) |
152305-23-2 |
|
| 2934990005 |
|
|
|
| USP-1A00010 |
Atorvastatin Ethyl Ester (25 mg) (ethyl (3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate) |
1146977-93-6 |
|
| 2933998350 |
|
|
|
| USP-1A00020 |
Atorvastatin Methyl Ester (25 mg) (methyl (3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate) |
345891-62-5 |
|
| 2933998350 |
|
|
|
| USP-1533035 |
Phenylephrine Related Compound D (30 mg) ((R)-3-{2-[Benzyl(methyl)amino]-1-hydroxyethyl}phenol) |
1367567-95-0 |
|
| 2922504500 |
|
|
|
| USP-1533046 |
Phenylephrine Related Compound E (30 mg) (2-[Benzyl(methyl)amino]-1-(3-hydroxyphenyl)ethan-1-one hydrochloride) |
71786-67-9 |
|
| 2922504500 |
|
|
|
| USP-1533261 |
Phenylephrine Related Compound F (30 mg) ((R)-2-Methyl-1,2,3,4-tetrahydroisoquinoline-4,8-diol hydrochloride monohydrate) |
1007885-60-0 |
|
| 2933497050 |
|
|
|
| USP-1533272 |
Phenylephrine Related Compound G (30 mg) ((R)-N-(2-Hydroxy-2-(3-hydroxyphenyl)ethyl)-N-methylglycine) |
1094089-46-9 |
|
| 2922504500 |
|
|
|
| USP-1533308 |
5-Phenylhydantoin (100 mg) |
89-24-7 |
|
| 2933210000 |
|
|
|
| USP-1534209 |
Phenyl Salicylate Melting Point Standard (1 g) (需冷链运输) (Approximately 41 degrees) |
118-55-8 |
UN3077 |
| USP-1534413 |
Phenyltoloxamine Related Compound A (50 mg) (2-(2-benzylphenoxy)ethylmethylamine hydrochloride) |
N/A |
|
| 2922299000 |
|
|
|
| USP-1535008 |
Phenytoin (200 mg) |
57-41-0 |
|
| 3822190000 |
|
|
|
| USP-1535019 |
Phenytoin Related Compound A (50 mg) (2,2-Diphenylglycine) |
3060-50-2 |
|
| 2922493800 |
|
|
|
| USP-1535020 |
Phenytoin Related Compound B (50 mg) (2,2-Diphenyl-2-ureidoacetic acid) |
6802-95-5 |
|
| 2924210000 |
|
|
|
| USP-1535507 |
Phenytoin Sodium (200 mg) |
630-93-3 |
|
| 2933290000 |
|
|
|
| USP-1535700 |
Phosphated Riboflavin (100 mg) |
6184-17-4 |
|
| 2936230000 |
|
|
|
| USP-1535899 |
Phthalic Acid (50 mg) |
88-99-3 |
|
| 2917394000 |
|
|
|
| USP-1535959 |
Phthalazine (20 mg) |
253-52-1 |
|
| 2933998350 |
|
|
|
| USP-1536509 |
Phyllanthin (15 mg) |
10351-88-9 |
|
| 3824999370 |
|
|
|
| USP-1536510 |
Powdered Phyllanthus Amarus Extract (1 g) |
N/A |
|
| 1302190200 |
|
|
|
| USP-1537003 |
Physostigmine Salicylate (200 mg) |
57-64-7 |
UN2811 |
| USP-1538505 |
Pilocarpine (300 mg) |
92-13-7 |
UN3140 |
| USP-1538902 |
Pilocarpine Hydrochloride (200 mg) |
54-71-7 |
UN1544 |
| USP-1539009 |
Pilocarpine Nitrate (200 mg) |
148-72-1 |
UN1544 |
| USP-1539508 |
Pimozide (200 mg) |
2062-78-4 |
|
| 2933399095 |
|
|
|
| USP-1539701 |
Pindolol (200 mg) |
13523-86-9 |
UN2811 |
| USP-1539803 |
Maritime Pine Extract (2 g) |
90082-75-0 |
|
| 3824995595 |
|
|
|
| USP-1539814 |
Pinitol (30 mg) |
10284-63-6 |
|
| 2909490000 |
|
|
|
| USP-1539905 |
Pioglitazone Hydrochloride (100 mg) |
112529-15-4 |
|
| 2934100000 |
|
|
|
| USP-1541500 |
Piperacillin (350 mg) |
66258-76-2 |
|
| 2941106000 |
|
|
|
| USP-1541529 |
Piperacillin Related Compound E (25 mg) (1-ethylpiperazine-2,3-dione) |
59702-31-7 |
|
| 2933599550 |
|
|
|
| USP-1541601 |
Piperazine (200 mg) |
110-85-0 |
UN2925 |
| USP-1541703 |
Piperazine Adipate (200 mg) |
142-88-1 |
|
| 2933599550 |
|
|
|
| USP-1541805 |
Piperazine Citrate (200 mg) |
144-29-6 |
|
| 2933599550 |
|
|
|
| USP-1541907 |
Piperazine Dihydrochloride (200 mg) |
207605-49-0 |
|
| 2933595960 |
|
|
|
| USP-1546296 |
Hydrogenated Polydextrose (200 mg) |
68424-04-4 |
|
| 3913908000 |
|
|
|
| USP-1546489 |
Polyethylene Glycol 1000 (1 g) |
25322-68-3 |
|
| 3907290000 |
|
|
|
| USP-1546525 |
Polyethylene Glycol 3000 (1 g) |
25322-68-3 |
|
| 3907290000 |
|
|
|
| USP-1546547 |
Polyethylene Glycol 3350 (1 g) |
25322-68-3 |
|
| 3907290000 |
|
|
|
| USP-1546569 |
Polyethylene Glycol 4000 (1 g) (alpha-hydro-omega-hydroxypoly(oxy-1,2-ethanediyl)) |
25322-68-3 |
|
| 3907290000 |
|
|
|
| USP-1548087 |
Ponceau 4R (50 mg) |
2611-82-7 |
|
| 3204120000 |
|
|
|
| USP-1548101 |
Potassium Benzoate (1 g) |
582-25-2 |
|
| 2916310002 |
|
|
|
| USP-1548134 |
Potassium Bicarbonate (1 g) |
298-14-6 |
|
| 2836400000 |
|
|
|
| USP-1548156 |
Potassium Alginate (100 mg) |
9005-36-1 |
|
| 3913100000 |
|
|
|
| USP-1548167 |
Potassium Carbonate (1 g) |
584-08-7 |
|
| 2836400000 |
|
|
|
| USP-1548190 |
Potassium Chloride (1 g) |
7447-40-7 |
|
| 3104200000 |
|
|
|
| USP-1548225 |
Potassium Citrate (1 g) |
6100/5/6 |
|
| 2918150000 |
|
|
|
| USP-1548280 |
Potassium Iodide (1 g) |
7681-11-0 |
UN3077 |
| USP-1548350 |
Potassium Nitrate Melting Point Standard (1 g) (Potassium Nitrate) |
7757-79-1 |
UN1486 |
| USP-1548407 |
Potassium Sorbate (1 g) |
24634-61-5 |
|
| 2916191000 |
|
|
|
| USP-1549807 |
Potassium Acetate (500 mg) (AS) |
127-08-2 |
|
| 2915299000 |
|
|
|
| USP-1549840 |
Potassium Bitartrate (3 g) (AS) |
868-14-4 |
|
| 2918130000 |
|
|
|
| USP-1550001 |
Potassium Gluconate (200 mg) |
299-27-4 |
|
| 2918160000 |
|
|
|
| USP-1551004 |
Potassium Guaiacolsulfonate (500 mg) |
78247-49-1 |
|
| 2909500000 |
|
|
|
| USP-1551128 |
Dibasic Potassium Phosphate (500 mg) |
7758/11/4 |
|
| 2835240000 |
|
|
|
| USP-1551139 |
Monobasic Potassium Phosphate (5 g) |
7778-77-0 |
|
| 2835240000 |
|
|
|
| USP-1551150 |
Potassium Sucrose Octasulfate (300 mg) |
73264-44-5 |
|
| 2940006000 |
|
|
|
| USP-1551300 |
Potassium Trichloroammineplatinate (25 mg) |
13820-91-2 |
UN3288 |
| USP-1551503 |
Povidone (100 mg) |
9003-39-8 |
|
| 3905998000 |
|
|
|
| USP-1553000 |
Pralidoxime Chloride (200 mg) |
14018-50-9 |
|
| 2933399095 |
|
|
|
| USP-1553768 |
Pramipexole Related Compound A (15 mg) ((S)-4,5,6,7-Tetrahydrobenzothiazole-2,6-diamine) |
106092-09-5 |
|
| 2934200000 |
|
|
|
| USP-1553815 |
Pramipexole Related Compound D (25 mg) ((R)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole dihydrochloride) |
104632-27-1 |
|
| 2934200000 |
|
|
|
| USP-1553837 |
Pramipexole Related Compound F (25 mg) ((6S,7R)-2-Amino-6-(propylamino)-4,5,6,7-tetrahydrobenzothiazol-7-ol) |
2166216-34-6 |
|
| 2934200000 |
|
|
|
| USP-1553848 |
Pramipexole Related Compound G (25 mg) ((6S,7S)-2-Amino-6-(propylamino)-4,5,6,7-tetrahydrobenzothiazol-7-ol) |
1001648-71-0 |
|
| 2934200000 |
|
|
|
| USP-1553859 |
Pramipexole Dihydrochloride Monohydrate (200 mg) |
191217-81-9 |
|
| 2934200000 |
|
|
|
| USP-1554002 |
Pramoxine Hydrochloride (400 mg) |
637-58-1 |
|
| 2934990005 |
|
|
|
| USP-1554104 |
Prasugrel Hydrochloride (150 mg) (5-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate hydrochloride) |
389574-19-0 |
UN3077 |
| USP-1554148 |
Prasugrel Related Compound D (15 mg) (5-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-one) |
150322-38-6 |
|
| 2934990005 |
|
|
|
| USP-1554192 |
Pravastatin 1,1,3,3-Tetramethylbutylamine (200 mg) |
151006-14-3 |
|
| 2918195000 |
|
|
|
| USP-1554206 |
Pravastatin Sodium (50 mg) |
81131-70-6 |
|
| 2918195000 |
|
|
|
| USP-1554217 |
Pravastatin Related Compound A (10 mg) (Sodium (3R,5R)-3,5-dihydroxy-7-[(1S,2R,3S,8S,8aR)-3-hydroxy-2-methyl-8-[[(2S)-2-methylbutanoyl]oxy]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] heptanoate) |
81093-43-8 |
|
| 2918195000 |
|
|
|
| USP-1554228 |
Pravastatin Related Compound B (20 mg) (sodium (3R,5R)-3,5-dihydroxy-7-((1S,2S,6R,8S,8aR)-6-hydroxy-2-methyl-8-((S)-2-methylbutanoyloxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoate) |
81176-41-2 |
|
| 2918195000 |
|
|
|
| USP-1554603 |
Praziquantel (200 mg) |
55268-74-1 |
|
| 2933595960 |
|
|
|
| USP-1554658 |
Praziquantel Related Compound A (20 mg) (2-benzoyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino [2,1-a]isoquinolin-4-one) |
54761-87-4 |
|
| 2933599550 |
|
|
|
| USP-1554669 |
Praziquantel Related Compound B (50 mg) (2-(cyclohexylcarbonyl)-2,3,6,7-tetrahydro-4H-pyrazino [2,1-a]isoquinolin-4-one) |
125273-86-1 |
|
| 2933599550 |
|
|
|
| USP-1554670 |
Praziquantel Related Compound C (50 mg) (2-(N-formylhexahydrohippuroyl)-1,2,3,4-tetrahydroisoquinolin-1-one) |
125273-88-3 |
|
| 2933790002 |
|
|
|
| USP-1554705 |
Prazosin Hydrochloride (350 mg) |
19237-84-4 |
|
| 2934990005 |
|
|
|
| USP-1554749 |
Prazosin Related Compound D (25 mg) (Furan-2-yl(piperazin-1-yl)methanone) |
40172-95-0 |
|
| 2934990005 |
|
|
|
